Semaglutide Side Effects: What to Expect (And When to Call Your Doctor)
- Most common: Nausea (44%), diarrhea (30%), vomiting (24%), which usually improve after 4-8 weeks
- Serious but rare: Pancreatitis (<1%), gallbladder problems (1-2%), thyroid tumors (boxed warning)
- Emerging concerns: Hair loss (~5%), “Ozempic face” from rapid weight loss
- Management: Slow dose increases, smaller meals, and staying hydrated reduce most symptoms
- When to call your doctor: Severe abdominal pain, persistent vomiting, or allergic reactions
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist: a medication that mimics a hormone your gut naturally produces after eating. It slows digestion, reduces appetite, and helps regulate blood sugar.
You might know it by its brand names:
- Ozempic: FDA-approved for type 2 diabetes
- Wegovy: FDA-approved for weight loss
- Rybelsus: Oral tablet form for diabetes
All three contain the same active ingredient. The difference is dosing and FDA-approved use. This matters because side effects are largely the same across brands.
According to prescribing data from 2024, over 9 million Americans filled a semaglutide prescription that year. With that many users, the side effect profile is thoroughly documented.
Common side effects
The clinical trials for Wegovy provide the most relevant data. Here’s what 1,961 participants reported in the STEP 1 trial:
| Side effect | Semaglutide | Placebo |
|---|---|---|
| Nausea | 44% | 17% |
| Diarrhea | 30% | 16% |
| Vomiting | 24% | 6% |
| Constipation | 24% | 11% |
| Abdominal pain | 20% | 11% |
Why this happens: Semaglutide slows gastric emptying, so food sits in your stomach longer. Your body isn’t used to this and interprets the sensation as nausea.
The good news: For most people, GI symptoms peak during dose increases and improve within 4-8 weeks. In clinical trials, fewer than 5% discontinued due to side effects.
Managing GI symptoms: Eat smaller meals (4-5 portions instead of 3). Avoid greasy or fried foods. Stay hydrated but don’t chug large amounts at once. Consider taking your injection at bedtime.
Other common side effects
- Headache: 14% vs 10% placebo
- Fatigue: 11% vs 6% placebo
- Dizziness: 8% vs 6% placebo
- Injection site reactions: Usually mild and temporary
These generally don’t require treatment changes and often resolve as your body adjusts.
Serious side effects (rare but important)
While most side effects are uncomfortable rather than dangerous, some require immediate medical attention.
Pancreatitis
Risk level: Rare (<1% in clinical trials)
Pancreatitis is inflammation of the pancreas. The FDA requires GLP-1 medications to include warnings based on post-marketing reports, though the actual risk appears low.
Symptoms to watch: Severe pain in your upper abdomen radiating to your back. Pain that worsens after eating. Nausea different from your baseline. Fever. Stop semaglutide and contact your doctor immediately.
Higher risk: History of pancreatitis, heavy alcohol use, or very high triglycerides.
Gallbladder problems
Risk level: 1-2% in clinical trials
Rapid weight loss, regardless of method, increases gallstone risk. In the STEP trials, gallbladder events occurred in 2.6% of semaglutide users versus 1.2% on placebo.
Symptoms: Pain in upper right abdomen after fatty meals. Pain radiating to shoulder or back.
Thyroid tumors (boxed warning)
Semaglutide caused thyroid C-cell tumors in rodents. After 5+ years of human use, no increased cancer signal has emerged. The warning exists because the rodent finding can’t be ethically tested in humans.
Who should avoid semaglutide: Anyone with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Kidney problems
Severe dehydration from vomiting or diarrhea can affect kidney function, especially in people with pre-existing kidney disease.
Prevention: Stay hydrated, especially during dose increases. If you can’t keep fluids down, contact your doctor.
Emerging concerns
Hair loss
In the STEP 1 trial, 3% reported hair loss versus 1% on placebo. Other studies report rates up to 5-6%.
This is likely telogen effluvium, a type of hair shedding triggered by rapid weight loss or nutritional changes. It’s not unique to semaglutide. The shedding typically resolves 6-12 months after weight stabilizes.
What helps: Adequate protein intake. A multivitamin with biotin, zinc, and iron.
“Ozempic face”
A social media term for facial volume loss with significant weight loss. You’re losing fat everywhere, including your face. Older adults and those losing weight quickly are most affected.
Muscle loss
In STEP 1, about 40% of weight lost was lean mass, which is higher than diet-alone weight loss.
Prevention: Strength training 2-3x per week. Protein intake of 0.7-1g per pound of body weight. Don’t restrict calories too severely.
How to minimize side effects
1. Follow the titration schedule
Semaglutide is dosed gradually for a reason:
- Weeks 1-4: 0.25mg
- Weeks 5-8: 0.5mg
- Weeks 9-12: 1mg
- Weeks 13-16: 1.7mg
- Week 17+: 2.4mg (maintenance)
Don’t rush this. People who skip doses or increase too fast have worse side effects.
2. Modify your diet
Your old eating patterns won’t work. Eat smaller portions. Avoid greasy and heavy foods. Aim for 64+ ounces of water daily.
3. Time your injection
Many people inject Friday evenings to adjust weekend plans if needed. There’s no medical reason to choose one day. Pick what works for you.
4. Track your symptoms
Keep a simple log: injection day, symptoms, severity (1-10), what you ate, what helped. This gives your doctor useful information.
Call your doctor if: You can’t keep food or water down for 24+ hours. Severe abdominal pain. Signs of dehydration (dark urine, dizziness). Side effects don’t improve after 4-6 weeks at the same dose.
Compounded semaglutide: different risks?
If you’re getting semaglutide from a compounding pharmacy (not brand-name Ozempic or Wegovy), additional considerations apply:
Quality variation: Compounded medications aren’t FDA-approved. Quality depends on the pharmacy’s standards.
Supervision matters: Getting compounded semaglutide through a reputable telehealth provider with medical oversight is different from an unknown source.
Read our guide on what compounded semaglutide is and see our provider reviews for companies with strong medical oversight.
Looking for a GLP-1 provider?
We’ve researched medical oversight, pricing, and patient experiences.
Compare providers →Frequently asked questions
The bottom line
Semaglutide side effects are real and common. Nearly half of users experience nausea during the first few months. For most, these effects are manageable and improve with time.
Serious side effects like pancreatitis and gallbladder problems exist but are rare. The thyroid cancer warning hasn’t translated into human risk after years of surveillance.
The key is working with a healthcare provider who can monitor your response, adjust your dose, and help you manage side effects effectively.
References
1. Wilding JPH, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. View source
2. FDA. Wegovy (semaglutide) Prescribing Information. View source
3. Rubino DM, et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight. JAMA.